Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
or without regard for the truth!
He has peeps listed who have full disclosures posted.
Now for the millions I am getting paid............... ROTFLMFAO!
Why are you even here as you outright lie in your bio?
WOOHOO
WOOHOO believes that IHUB enables the criminals here
Add Person Mark Send A Private Message
Read Last 50 Messages Ignore this Poster
Membership Type:
PeopleMarked By: 7
Location:
Age:
Interests/Hobbies: Stopping by IHUB to watch the latest scam play out
Favorite Stocks: Anything but a pink
Investment Philosophy: Mix of LT and DT
Job/Title:
Favorite Links: I Group (required reading)
IHUB Promoters
Quote:
Alias Born On: Thursday, March 02, 2006
Boards Moderated: 1
Total Posts: 1101
Eye group is a lie and a scam, and you are a scammer for promoting the lies!
A false statement is fraudulent if it is made knowingly, without believing it to be true.
ADL up 5% at $1.03. Nice support on the bid.
ADL has anemic volume but it's holding up around the $1.00 level. I've added a few over the last several days. Good bid support at this level.
Took profits in UVE over last 2 days. Insurance Companies are getting hit again due to Allstate's dismal earnings yesterday.
Depending on market conditions I possibly will try to add on 10% dips.
Great trade on UVE.
UVE still rocking, up 4% at $3.61. Congrats to all who held.
ADL up 19% at $1.12.
UVE up 5% at $3.40. Growth stocks kicking ass today!!
ADL up 10% at 1.03. Great news today!
UVE closed up 5% @ $3.23. Great week for UVE, up 13% on a short week. Today's volume was the highest of the week.
UVE up again 3% @ 3.18
UVE continues upward, up 3% at 3.11.
UVE up 4% at 3.03
UVE breaking out at $2.95. Up yesterday in an ugly market.
ADL up 17% at $1.40
ADL now up 43%
ADL now up 8% at 1.22.
ADL is all over the map today. It looks like it might continue it's recent move to the upside.
ADL exploding today. You saw it here first at Growth Stocks.
It looks like we have some buying interest in ADL which is a good sign for the long-term. I will probably look to add to my position on any weakness.
ADL listed as the top stock pick for 2009 by Bob Flaherty. From what I've read about Bob Flaherty's picks is that anybody associated with the Company is prohibited from initiating a position in his picks for 10 business days after the release of his newsletter which in this case will be December 19th. In addition they are not compensated for their picks.
http://archive.constantcontact.com/fs070/1101855435216/archive/1102359574659.html
Still adding shares on dips and will anxiously await additional guidance from the Company. There are still some warning signs out there that need to be addressed.
UVE getting some love today on lower than average volume.
Ok, let me know if you need any help
have a great weekend woohoo
Thanks Tina. I will take a look at it.
Hi WOOHOO
Looking good bud!
the new iboxes have a cool tool called a "table" that lines up all your data so it's really even and nice looking. You can even add color to it as well (just not the font).
Check out the Tables that I did for Wealth University:
http://investorshub.advfn.com/boards/board.aspx?board_id=10933
ADL closed up 36% @ $1.09 on low volume.
Added ADL @ $.66 today. I will be featuring this Company in the very near future.
Order @ $.66 has not fully filled if anybody wants to bidwhack :)
Started a position in ADL @ .78. This will probably be the first pick in the growth portfolio. I intend to finish my DD tonight.
Added UVE today at 2.68 and 2.72. This does not qualify for the growth stocks portfolio but I feel that it represents significant value at these levels. Insurance companies are taking a beating at the moment so I will add on each 5% dip.
Hippy?? LOL but wrong on that one :)
woohoo
take the *'s out of the code and you should be fine
Took a starter position in STMF (1.95 x 1.98). Guidance issued today for FY 08 earnings of $.23 to $.27 represents around a 300% increase from FY 07 earnings of $.06. I will add on dips and looking for this to test the 52 week high of $2.45.
GLTA
Nice to take a look at COPI - earnings this week, keep it on the back burner...
As promised I took a look at COPI but have decided not to include this in my growth portfolio. The reasons for this are described below.
1. I don't see the Company reporting a profit in the near future. I saw that a poster was projecting Net Income this quarter but my research shows otherwise. The poster in question projects SG&A of 268K for the quarter. I don't know where this number came from. Last quarter showed an actual SG&A of 613K which included over 200K of non-recurring charges. This shows a run rate of over 400K which has been steadily increasing. With SG&A at 400K+ the Company needs to show sales of over 900K to achieve break-even. This is a significant increase over the 467K in sales for each of the last 2 quarters.
2. I just can't get past the dilution of the Company stock. Yes I know that they need to issue stock to grow but the Shares Outstanding has increased from 50M in the June 2007 quarter to 130M in the March 2008 quarter. This is a 160% increase in shares over the previous 9 months.
I wish you the best of luck with COPI. I will continue to monitor their financial situation and will await a time when they can project profitability without serious dilution.
GLTY
Check the COPI - I-box - Growth stalled in the 4th quarter, but picked up again in the 1st quarter, and 2nd quarter financials are due on the 15th of August... They hired this ex-Microsoft executive with a lot of major connections... have hired an investment banker, and have raised funds for "an acquisition". One that could WOOHOO if the NEWS is good... Last year ran from .001 to .11 from July thru Jan. 08, has retraced back to .009 and seems to be slowly basing again here..
GLWI
I will take a look at COPI. Can you direct me to any information concerning forward looking statements? I don't see any growth from their previous financials (admittedly I only gave it a quick look).
He he he, you got my attention... now... Where are the picks?
Start with COPI
anytime woohoo :)
LOL thanks Tina. Lots of work to do here. Thanks again for your help. I'm going to need it!
Followers
|
2
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
51
|
Created
|
07/16/08
|
Type
|
Premium
|
Moderators |
This site is for growth stocks only.
Only Companies that are generating revenue will be featured in this forum.
Only stocks that are projecting profit (within the next 12 months) will be featured in this forum.
Only OTCBB, Nasdaq, AMEX and NYSE stocks will be featured in this forum. NO PINKIES!
Growth analysis will be performed on all stocks that qualify for this thread. An estimated PPS will be provided as a 12-month target for each Company.
If you would like a stock to be mentioned in this forum please provide a Company name and any necessary links that will add value in the course of DD.
PROJECTED REVENUE AND/OR PROFIT MUST BE VERIFIED FOR A COMPANY TO BE INCLUDED ON THIS THREAD.
Best of luck to all and let's all make some money.
Growth Company Profile on AMDL, Inc. (AMEX:ADL)
WOOHOO IS ISSUING A STRONG BUY RATING ON ADL WITH A 12 MONTH TARGET OF $3.20
I AM PROJECTING 2009 EPS OF $.32 BASED UPON THE COMPANY GUIDANCE FOR 2009.
THIS ESTIMATE IS CONSERVATIVE AND HAS UPSIDE POTENTIAL IF COMPANY GUIDANCE IS REALIZED.
Profile:
AMDL, Inc., specialty pharmaceutical company, through its subsidiary, Jade Pharmaceutical, Inc., engages in the research, development, manufacture, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products primarily in China. The company offers DR-70 diagnostic test kit, a tumor-marker biochemical substance, which is used to detect various cancers, including lung (small and non-small cell), stomach, breast, rectal, colon, and liver cancer. The company?s product line also includes a line of non-proprietary cancer tumor markers and non-proprietary test kits, including CEA for colon cancer and PSA for prostate cancer. AMDL also owns a Combination Immunogene Therapy technology. In addition, the company, through its subsidiary, Jade Pharmaceutical, Inc., manufactures large volume injectible fluids, tablets, and over-the-counter pharmaceutical products. The company?s product line also includes diagnostic test kits for infectious diseases, endocrinology, diabetes, nephrology, and allergy. It sells its products through distributors to hospitals, clinical research and forensic laboratories, and doctor?s offices. The company was founded in 1988 and is based in Tustin, California.
SELECTED FINANCIAL INFORMATION
|
3RD QUARTER 2008 RESULTS SHOWING EPS OF FULLY DILUTED EPS OF $.09 IN THE QUARTER
http://biz.yahoo.com/prnews/081117/lam061.html?.v=101
PRELIMINARY 2009 GUIDANCE
http://biz.yahoo.com/prnews/081118/latu083.html?.v=101
SEC Filings
http://yahoo.brand.edgar-online.com/default.aspx?cik=838879
Chart
http://stockcharts.com/h-sc/ui?s=adl
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |